SIDERO BIOSCIENCE, LLC
HERSHEY, PA · CIK 0001686384 · Biotech · Private
Iron delivery system for oral supplements with reduced gastrointestinal side effects
siderobio.com →- Grants
- $525K
- 2 awards
- Sector median: 1
- Raised
- $145K
- 1 Form D · Oct 2016
- 120 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 9
- 1 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Novel Medical Food for the Management of Iron Deficiency Anemia | $224,836 | |
| Private capital raised | Form D · SEC | $145,000 | |
| Federal grant | Department of Health and Human Services · Phase I · BioFe Mechanism of Action for the treatment of iron deficiency anemia | $299,955 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2647 | STEMSAVE INC | — | $150K |
| 2648 | ViroMissile, Inc. | — | $150K |
| 2649 | Integrated Micro-Chromatography Systems, Inc. | — | $150K |
| 2650 | SIDERO BIOSCIENCE, LLC | — | $145K |
| 2651 | ORION THERAPEUTICS INC. | — | $145K |
| 2652 | Finch Therapeutics, Inc. | — | $4.5M |
| 2653 | TARTAN LLC | — | $130K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Michael ArmstrongDirector · Executive Officer
- James ConnorDirector · Executive Officer
- Robert HarbaughDirector · Executive Officer
- Ralph KeilExecutive Officer
- Silvan Lutkewitte, IIIDirector · Executive Officer
- Darren WolfeDirector · Executive Officer
Patents
- Compositions And Methods For Improvement Of Iron Metabolism And Gut Microbiome Healthgranted
- Recombinant Hosts Comprising Ferritin Or Homologues Thereofapplication
- Ferritin Composition Tolerabilityapplication
- Ferritin Composition Tolerabilityapplication
- Recombinant Hosts Comprising Ferritin Or Homologues Thereofapplication
- Compositions And Methods For Improvement Of Iron Metabolism And Gut Microbiome Healthapplication
- Composition And Method For Treatment Of Iron Deficiencyapplication
- Recombinant Hosts Comprising Ferritin Or Homologues Thereofapplication
- Ferritin Composition Tolerabilityapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.